Neuroendocrine Prostate Cancer Market is driven by precision therapeutics
The Neuroendocrine Prostate Cancer Market comprises a spectrum of targeted therapies, diagnostic assays, and supportive care products designed to manage this aggressive cancer subtype. Key offerings include peptide receptor radionuclide therapies (PRRT), novel small-molecule inhibitors, monoclonal antibodies, and advanced imaging agents that facilitate early detection and precision treatment....
0 Commentaires 0 Parts 38 Vue 0 Aperçu